Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
GLOBETECH PUBLISHING

Carestream’s Preclinical in Vivo Imaging Business to Be Acquired by Bruker

By BiotechDaily International staff writers
Posted on 05 Oct 2012
Carestream Health (Rochester, NY, USA) and Bruker Corp. (Billerica, MA, USA) have entered into an agreement for Bruker to purchase the preclinical in vivo imaging equipment product range and related assets from Carestream’s molecular imaging business. Financial terms of the agreement are not being disclosed.

Carestream will retain the remaining assets of its molecular imaging business, including its life science X-ray film product lines and its Gel Logic and Image Station in vitro imaging equipment-product range. Carestream will continue operating its life science X-ray film business, and will continue to support its in vitro product customers with service and parts. New production of its Gel Logic and Image Station in vitro products will be discontinued.

Dr. Werner Maas, president of Bruker BioSpin Corp., commented, “We are excited about adding Carestream’s in vivo imaging systems to our preclinical imaging product portfolio. We believe that Carestream’s optical molecular imaging product line will complement our other preclinical solutions, presently consisting of magnetic resonance imaging [MRI], magnetic particle imaging [MPI] and X-ray micro computed tomography [microCT]. We also welcome the talented Carestream in vivo employees to Bruker, and look forward to their contributions.”

Carestream Health is a worldwide provider of dental and medical imaging systems and healthcare information technology (IT) solutions; X-ray film and digital X-ray systems for nondestructive testing; and sophisticated materials for the precision films and electronics markets.

Bruker Corp. is a provider of scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analysis.

Related Links:
Carestream Health
Bruker



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Diagram illustrates the innovative process that could lead to more effective drugs against influenza infection (Photo courtesy of the Hebrew University of Jerusalem).

Researchers Show How the Influenza Virus Blocks Natural Killer Cell Recognition

A team of molecular virologists has described how the influenza virus evolved a defense mechanism to protect it from attack by the immune system's natural killer (NK) cells. The recognition of pathogen-infected... Read more

Drug Discovery

view channel
Image: Synthetic ion transporters can induce apoptosis by facilitating chloride anion transport into cells (Photo courtesy of the University of Texas, Austin).

Experimental Drug Kills Cancer Cells by Interfering with Their Ion Transport Mechanism

An experimental anticancer drug induces cells to enter a molecular pathway leading to apoptosis by skewing their ion transport systems to greatly favor the influx of chloride anions. To promote development... Read more

Therapeutics

view channel
Image: Liver cells regenerated in mice treated with a new drug (right) compared with a control group (center) after partial liver removal. Healthy liver cells are shown at left (Photo courtesy of Marshall et al, 2014, the Journal of Experimental Medicine).

New Drug Triggers Liver Regeneration After Surgery

Investigators have revealed that an innovative complement inhibitor decreases complement-mediated liver cell death, and actually stimulates postsurgery liver regrowth in mice. Liver cancer often results... Read more

Lab Technologies

view channel

Genome-Wide Mutation-Searching Computational Software Designed for Genomic Medicine

Analysis software cross-references a patient’s symptoms with his genome sequence to help physicians in the diagnosis of disease. This software was created by a team of scientists from A*STAR’s Genome Institute of Singapore (GIS), led by Dr. Pauline Ng. The research findings were published August 3, 2014, in the journal... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.